SCHEMBL2553365

SCHEMBL2553365

CC(C(=O)O)N(C)N

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1548945 1.00
SCHEMBL8043890 0.79
SCHEMBL8744761 0.79 TP53 (0.42)
SCHEMBL8043887 0.79
SCHEMBL27555384 0.78 TP53 (0.36)
Hydrochloric Acid SCHEMBL28723645 0.77
Hydrazine SCHEMBL2231840 0.77 TP53 (0.40)
Hydrazine SCHEMBL2231845 0.77 TP53 (0.40)
SCHEMBL14971110 0.77
SCHEMBL754117 0.75

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020081958-A2 COMPOSITIONS AND METHODS FOR IDENTIFYING MUTATIONS OF GENES OF MULTI-GENE SYSTEMS HAVING IMPROVED FUNCTION THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE (US) 2020-04-23 WO claimed
US-12338209-B2 Astaxanthin esters and methods of use thereof CARDAX, INC. (US) 2025-06-24 US disclosed
US-20220380306-A1 ASTAXANTHIN ESTERS AND METHODS OF USE THEREOF CARDAX, INC. 2022-12-01 US disclosed
US-20220340893-A1 BI-FUNCTIONAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES NUEVOLUTION A/S (DK) 2022-10-27 US disclosed
EP-4034525-A1 ASTAXANTHIN ESTERS AND METHODS OF USE THEREOF Cardax, Inc. (US) 2022-08-03 EP disclosed
US-11225655-B2 Bi-functional complexes and methods for making and using such complexes NUEVOLUTION A/S (DK) 2022-01-18 US disclosed
WO-2021062237-A1 ASTAXANTHIN ESTERS AND METHODS OF USE THEREOF CARDAX, INC. (US) 2021-04-01 WO disclosed
EP-3540059-A1 BI-FUNCTIONAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES Nuevolution A/S (DK) 2019-09-18 EP disclosed
EP-2558577-B1 BI-FUNCTIONAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES NUEVOLUTION AS (DK) 2018-12-12 EP disclosed
EP-2782566-A1 L-SERINE COMPOSITIONS, METHODS AND USES FOR TREATING NEURODEGENERATIVE DISEASES AND DISORDERS The Institute for Ethnomedicine (US) 2014-10-01 EP disclosed
US-20130281324-A1 BI-FUNCTINAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES NUEVOLUTION A/S (DK) 2013-10-24 US disclosed
WO-2013078395-A1 L-SERINE COMPOSITIONS, METHODS AND USES FOR TREATING NEURODEGENERATIVE DISEASES AND DISORDERS THE INSTITUTE FOR ETHNOMEDICINE (US) 2013-05-30 WO disclosed
EP-2558577-A1 BI-FUNCTIONAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES Nuevolution A/S (DK) 2013-02-20 EP disclosed
WO-2011127933-A1 BI-FUNCTIONAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES NUEVOLUTION A/S (DK) 2011-10-20 WO disclosed
WO-2003004141-A2 KINASE MIMIC CATALYSTS FOR ASYMMETRIC SYNTHESIS OF PHOSPHORYLATED INSITOLS AND CYCLOALKANOLS THE TRUSTEES OF BOSTON COLLEGE (US) 2003-01-16 WO disclosed